Paclitaxel hypersensitivity reactions: A role for docetaxel substitution [1]

Annals of Oncology

Volumn 9, Issue 5, 1998, Pages 573-574

  Lokich, J ^a   Anderson, N ^a  

^a Cancer Center of Boston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CREMOPHOR; DEXAMETHASONE; DOCETAXEL; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; PACLITAXEL;

ADULT; BREAST CANCER; BRONCHOSPASM; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DYSPNEA; FEMALE; FLUSHING; HUMAN; HYPERTENSION; LETTER; LUNG CANCER; MALE; OVARY CANCER; PRIORITY JOURNAL;

EID: 0031840753     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1008272114546     Document Type: Letter

References (6)

1. Weiss R.B. Donehower R.C. Wiernik P.H. Hypersensitivity reactions from TaxoI J Clin Oncol 8 1990 1263 1268
2. Dye D. Watkins J. Suspected anaphylactic reaction to Cremophor El BMJ 280 1980 1353
3. Peereboom D.M. Donehower R.C. Eisenhauer E.A. Successful re-treatment with Taxol after major hypersensitivity reactions J Clin Oncol 11 1993 885 890
4. Francis P.A. Rigas J.R. Kris M.G. Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer J Clin Oncol 12 1994 1232
5. Pazdur R. Lassere Y. Soh L.T. Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma Ann Oncol 5 1994 468
6. Verweij J. Clavel M. Chevalier B. Paclitaxel (Taxol) and docetaxel (Taxotere): Not simply two of a kind Ann Oncol 5 1994 495